Updated

By Lawrence Hurley and Andrew Chung WASHINGTON (Reuters) – U.S. Supreme Court justices...

By David Morgan and Richard Cowan WASHINGTON (Reuters) – The U.S. House of Representatives...

By Andrea Shalal and Stephanie Nebehay WASHINGTON/GENEVA (Reuters) – The World Health...

By Babak Dehghanpisheh DUBAI (Reuters) – Coronavirus has spread to almost all of...

By Josh Smith and Sangmi Cha SEOUL (Reuters) – South Korea reported hundreds of new...

By Andrew Galbraith and David Stanway SHANGHAI (Reuters) – Scientists in China studying the...

ZURICH (Reuters) – Roche has won fast-track review status in the United States for a new...

BEIJING/SHANGHAI (Reuters) – China is encouraging producers of protective suits for medical...

MELBOURNE (Reuters) – An Australian court on Tuesday ordered Johnson & Johnson to pay...

By Roxanne Liu and John Miller BEIJING/ZURICH (Reuters) – China has approved the use of...

By Junko Fujita and Chris Gallagher TOKYO (Reuters) – Takeda Pharmaceutical Co said on...

By Byron Kaye and Colin Packham SYDNEY (Reuters) – Australia’s major grocers put...

By Kate Kelland LONDON (Reuters) – More than half of UK smokers now wrongly believe that...

By Steve Gorman and Hilary Russ (Reuters) – Three more deaths from the coronavirus were...

By Stephanie Nebehay and Kate Kelland GENEVA/LONDON (Reuters) – About 3.4% of confirmed...

By Jonathan Stempel (Reuters) – The United States sued a unit of the drugmaker Mallinckrodt...

By Reuters Staff LONDON (Reuters) – The last patient being treated for Ebola in Democratic...

ZURICH (Reuters) – Roche has won U.S. breakthrough therapy status for Esbriet for...

By Chris Thomas and Neha Dasgupta BENGALURU/NEW DELHI (Reuters) – India, the world’s...

By Laila Kearney and Maria Caspani NEW YORK (Reuters) – Less than a year after Constantine...